Skip to main content

nl
fr
en

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Human medicines
Health Products
Medical devices and their accessories
Materiovigilance

Materiovigilance

What shall be notified?

Who should notify?

When must incidents be notified?

How should incidents be notified?

Last updated on 20/05/2009

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

24/03/2019

Give your opinion on a clinical trial with a genetically modified medicinal product in Pediatric Subjects With Advanced Noncentral Nervous System Tumors That are Amenable to Direct Injection.

15/03/2019

Now there is also an online reporting form available for patient reporting of side effects of drugs

13/03/2019

Flash VIG-news: 5-fluorouracil and capecitabine - Recommendations for a deficiency of dihydropyrimidine dehydrogenase (DPD)

08/03/2019

Metal-on-metal hip prostheses - revision of recommendations

All news

© 2016 - FAMHP

Site map
Disclaimer
Complaints
Contact